The HTAsiaLink Annual Conference for this year happened on 4 – 7 September, hosted by the Malaysia Health Technology Assessment Section (MaHTAS) under the Ministry of Health, Malaysia. Researchers from HITAP participated in the conference and presented their research projects thr

On 2 Dec 2022, our outstanding presenters received big achievements by winning amazing awards at the 10th HTAsiaLink Annual Conference 2022 which virtually held on 30 November – 2 December 2022. The winners are as listed below:Best Oral PresentationsTrack: Economic EvaluationSecond Prize: Chittawan

The more controversial of two papers describing how the lethal H5N1 bird flu could be made easier to spread was published Thursday, six months after a scientific advisory board suggested that the papers’ most potentially dangerous data be censored.The paper, by scientists at Erasmus Medical Center i

By Branwen Jeffreys and Nick Triggle BBC NewsAn NHS hospital trust has been formally warned it could be declared bust – in the first case of its kind.South London Healthcare, which runs three hospitals, had debts of £69m at the start of the financial year.The health secretary has told the trust an a

WASHINGTON — It would seem a business executive’s dream: legally pay a competitor to keep its product off the market for years.Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it.Until th

Drug-resistant HIV has been increasing in parts of sub-Saharan Africa over the last decade, according to experts writing in the Lancet.Studies on 26,000 untreated HIV-positive people in developing countries were reviewed by the team.They said resistance could build up if people fail to stick to drug

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

Welcome to iDSI, the international Decision Support Initiative. We provide a platform for supporting low and middle income country (LMIC) policymakers in making better use of healthcare resources to generate maximum health, in their journeys towards universal health coverage (UHC).

As part of a series of events coinciding with the launch of the Gates Reference Case, Tommy Wilkinson (Adviser for Health Economics, NICE International) will be speaking on Tuesday 17 June 2014 at a lunch seminar hosted by the Center for Global Development, Washington DC. If you missed our launch ev

This is a post by Amanda Glassman reproduced with permission from the Center for Global DevelopmentCost-effectiveness studies compare the costs and benefits of different interventions with the aim of improving decisions on the allocation of scarce resources for health.  Or, put simply, they allow po